Mon, Sep 16, 2019
Government is considering a clear and more effective guideline to deal with the issue of recall of drugs which are Not of Standard Quality (NSQ). Drug Consultative Committee (DCC) under the ministry of health and family welfare has approved the recommendation of the sub-committee for effective recall system.
More >
Sat, Mar 09, 2019
The maximum retail price of 390 non-scheduled cancer medicines have been reduced by up to 87 per cent
Sat, Mar 25, 2017
In 2015, Europe banned around 700 medicines that had been approved based on clinical trial data provided by GVK Biosciences, then India’s largest CRO.
Mon, Jan 30, 2017
Piramal Enterprises UK-based subsidiary Piramal Critical Care has entered into an agreement with Mallinckrodt for acquiring the drugs.
Tue, Dec 13, 2016
The US regulator has once gain raised concerns of the quality control process at one of its factories.
Mon, Dec 12, 2016
Glenmark and its partner Endo will be entitled to 180 days of generic drug exclusivity for ezetimibe.
Mon, Aug 15, 2016
"Except for a couple of CNS (central nervous system) products and one pain product, we are not really missing a major portfolio. We are looking at couple of global products, though they have gone all off LOE (loss of exclusivity) to reintroduce them into India, we are also looking at that aspect of this juncture," Pfizer India Managing Director S Sridhar told analysts.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
